Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00440830 · ClinicalTrials.gov registry record · Phase 4
Nicotine Patch as an Analgesic Adjuvant After Surgery
A Phase 4 study of Pain, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT00440830: Completed Phase 4 study of Pain, sponsored by Columbia University.
NCT00440830 is a Phase 4 study of Pain that has completed, run by Columbia University. The registered enrollment target is 68 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00440830, a Phase 4 study of Pain, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
Effect of nicotine patch as an adjutant for acute pain after surgery.
Primary Outcome
Postoperative pain reported after the first hour using a standard numerical rating scale (NRS) with 0=no pain and 10=worst pain imaginable.
Conditions Studied
Interventions
- DRUG placebo
- DRUG nicotine patch
Study Locations (1)
New York
- Columbia University Irving Medical Center / New York Presbyterian - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
What the finished NCT00440830 record still lists
NCT00440830 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00440830 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00440830 about?
NCT00440830 is a clinical study titled "Nicotine Patch as an Analgesic Adjuvant After Surgery". Effect of nicotine patch as an adjutant for acute pain after surgery.
What is the current status of trial NCT00440830?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2005-12. Estimated completion is 2008-12.
What conditions does trial NCT00440830 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT00440830?
The interventions under investigation include: placebo (DRUG), nicotine patch (DRUG).
Who is sponsoring clinical trial NCT00440830?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00440830 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00440830's enrollment target sits among peer trials
68 217th of 374 higher than 155 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia